Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Birgitte H. Bendixen"'
Autor:
Janet Wilterdink, Michael D. Hansen, Robert F. Woolson, Birgitte H. Bendixen, William R. Clarke, Harold P. Adams
Publikováno v:
Stroke. 32:2836-2840
Background and Purpose — Although the efficacy of aspirin in reducing stroke incidence is clear, its role in reducing stroke severity is disputed. This study compares stroke severity between patients who did or did not take aspirin in the week befo
Autor:
Karla J. Grimsman, Patricia H. Davis, Patricia A. Wasek, Betsy B. Love, Robert F. Woolson, Harold P. Adams, William R. Clarke, Birgitte H. Bendixen
Publikováno v:
Controlled Clinical Trials. 18:358-377
TOAST is a multicenter, randomized, placebo-controlled clinical trial testing the usefulness of a new antithrombotic drug in improving the outcome of persons with acute ischemic stroke. Until recently, no clinical trial testing a treatment for ischem
Publikováno v:
Cerebrovascular Diseases. 3:364-369
Randomly selected primary care physicians in Iowa (n = 250) or The Netherlands (n = 250) received a questionnaire asking their opinions about management of patients with ischemic stroke of recent onse
Publikováno v:
Current neurology and neuroscience reports. 1(1)
Data from studies of 337 children and 1606 young adults are summarized to identify the major causes of stroke in these age groups. In children under 15 years of age, stroke occurs in patients with congenital heart disease, nonatherosclerotic vasculop
Autor:
Birgitte H. Bendixen, Lenore Ocava
Publikováno v:
Current cardiology reports. 4(2)
Stroke continues to be a major cause of adult mortality and disability. After numerous clinical trials and hundreds of millions of dollars spent on research, only two drugs are effective in treating patients with acute stroke. Recombinant tissue-plas
Autor:
Harold P. Adams, K.-C. Chang, Birgitte H. Bendixen, Robert F. Woolson, Michael D. Hansen, Enrique C. Leira, W.R. Clarke, Patricia H. Davis
Publikováno v:
Neurology. 53(1)
Objective: To examine the responses to early IV administration of an anticoagulant or placebo started within 24 hours of stroke among persons with an ipsilateral occlusion or severe stenosis of the internal carotid artery (ICA) identified by carotid
Autor:
Harold P. Adams, B. Razavi, J.E. Maley, Birgitte H. Bendixen, Mehrdad Razavi, M. Zargarian, M. Shoaib
Publikováno v:
Scopus-Elsevier
Article abstract The authors report a patient with angiographic findings resembling CNS vasculitis (CNS pseudovasculitis) who was found to have a pheochromocytoma. The angiographic changes resolved after surgical resection of the pheochromocytoma. Ph
Publikováno v:
Gastrointestinal endoscopy. 47(1)
Autor:
William T. C. Yuh, Toshihiro Ueda, Ming Wang Zhu, Masayuki Maeda, Birgitte H. Bendixen, Jerome P. Quets, Joan E. Maley, Gregory J. Lawler, Daniel L. Crosby, Ghi Jai Lee
Publikováno v:
Journal of magnetic resonance imaging : JMRI. 7(1)
The availability of new therapeutic interventions, including neuroprotective agents and endovascular thrombolysis, has given new hope to patients suffering an acute stroke. Early intervention remains a key factor in the effectiveness of these new and
Autor:
Robert F. Woolson, Culebras A, Patricia H. Davis, William R. Clarke, Birgitte H. Bendixen, Harold P. Adams
Publikováno v:
Neurology. 46(4)
To determine the frequency, location, size, and risk factors for silent cerebral infarctions (SCIs) on brain CT, we identified 629 patients without a history of previous stroke who were enrolled in a multicenter clinical trial of therapy for acute is